Antibody Study Grants One Step Further Towards The COVID-19 Vaccine

Antibody Study Grants One Step Further Towards The COVID-19 Vaccine
SHARE

The world seems helpless in the face of the COVID-19 pandemic. Hundreds of thousands of people died worldwide, and the doctors’ and scientis’ quest for a vaccine seems endless. Will the world ever get away from this terrible scourge? How many people will still have to die because of the SARS-CoV-2 virus? You know what they say: hope dies last. Not to mention that scientists’ thirst for progress is stronger than any pandemic that ever existed in the history of humanity.

As in pretty much every other disease, people infected with the COVID-19 disease develop antibodies so that they won’t get reinfected at least for four months. This news can offer tremendous help for scientists to finally provide a vaccine.

Immunity for COVID-19 may not be fleeting

The good news can be even more exhilarating, as scientists from Harvard University and the U.S. National Institutes of Health stated that a vaccine can provide hope that “immunity to this unpredictable and highly contagious virus may not be fleeting,”

Reykjavik-based deCODE Genetics made the new study, which is a subsidiary of the U.S. biotech company Amgen.

It was reported recently that about 172 countries are currently working hard to find a vaccine for the SARS-CoV-2 virus. The drugmaker AstraZeneca even has high hopes for bringing a potential vaccine for the deadly virus pretty soon. The company is even optimistic that it can make a staggering amount of 3 billion doses as soon as the vaccine is done. That means that over a third of the world population is assured that it will be avoided by COVID-19 in the future.

Over 860,000 people from all over the world died because of the ongoing pandemic, and the total number of infected ones exceeds 26 million. Unfortunately, these numbers keep growing.


SHARE

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.